150 related articles for article (PubMed ID: 405356)
1. Mode of action of the protein, SP127, which enhances the activity of macrolide antibiotics against Pseudomonas aeruginosa.
Kikuchi M; Nakao Y
J Antibiot (Tokyo); 1977 Mar; 30(3):215-20. PubMed ID: 405356
[TBL] [Abstract][Full Text] [Related]
2. SP127, a bacterial protein enhancing the activity of macrolide antibiotics against Pseudomonas aeruginosa: isolation and characterization.
Kikuchi M; Nakao Y
J Antibiot (Tokyo); 1977 Mar; 30(3):209-14. PubMed ID: 405355
[TBL] [Abstract][Full Text] [Related]
3. Vanillin selectively modulates the action of antibiotics against resistant bacteria.
Bezerra CF; Camilo CJ; do Nascimento Silva MK; de Freitas TS; Ribeiro-Filho J; Coutinho HDM
Microb Pathog; 2017 Dec; 113():265-268. PubMed ID: 29107747
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondoh K; Hashiba M
Nihon Jibiinkoka Gakkai Kaiho; 1998 Jan; 101(1):25-36. PubMed ID: 9493436
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondo K; Hashiba M; Baba S
Jpn J Antibiot; 1997 Mar; 50 Suppl A():102-5. PubMed ID: 9597456
[No Abstract] [Full Text] [Related]
6. Decrease in accumulation of macrolide antibiotics as a mechanism of resistance in Staphylococcus aureus.
Yamagishi S; Nakajima Y; Inoue M; Oka Y
Jpn J Microbiol; 1971 Jan; 15(1):39-52. PubMed ID: 5313613
[No Abstract] [Full Text] [Related]
7. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 3. Incorporation of [14C]midecamycin acetate (MOM) into P. aeruginosa pretreated with cell wall-affecting antibiotics.
Kasai T; Tomita T; Kanegasaki S; Homma JY
J Antibiot (Tokyo); 1982 Aug; 35(8):1086-92. PubMed ID: 6815146
[TBL] [Abstract][Full Text] [Related]
9. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Tateda K; Ishii Y; Matsumoto T; Kobayashi T; Miyazaki S; Yamaguchi K
J Infect Chemother; 2000 Mar; 6(1):1-7. PubMed ID: 11810524
[TBL] [Abstract][Full Text] [Related]
10. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
Knothe H
Infection; 1977; 5(3):137-9. PubMed ID: 914361
[TBL] [Abstract][Full Text] [Related]
11. New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
Karine de Sousa A; Rocha JE; Gonçalves de Souza T; Sampaio de Freitas T; Ribeiro-Filho J; Melo Coutinho HD
Microb Pathog; 2018 Oct; 123():368-371. PubMed ID: 30056107
[TBL] [Abstract][Full Text] [Related]
12. [Increased antibacterial activity of antibiotics with etonium in vitro].
Petrunyk IO
Mikrobiol Z; 2000; 62(4):43-6. PubMed ID: 11421003
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 1. Combined effects of a macrolide and a peptide antibiotic.
Kasai T; Homma JY
J Antibiot (Tokyo); 1982 Mar; 35(3):343-8. PubMed ID: 6281226
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antibacterial effects of Buddleja albiflora metabolites with antibiotics against Listeria monocytogenes.
Zhang X; Wang L; Mu H; Wang D; Yu Y
Lett Appl Microbiol; 2019 Jan; 68(1):38-47. PubMed ID: 30298931
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of ayurvedic pearl preparation on enhancing effectiveness of antibiotics.
Kulkarni M; Deopujari JY; Purohit HJ
Indian J Exp Biol; 2002 Jul; 40(7):831-4. PubMed ID: 12597554
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
17. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.
PATTEE PA; BALDWIN JN
J Bacteriol; 1962 Nov; 84(5):1049-55. PubMed ID: 13941896
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
[TBL] [Abstract][Full Text] [Related]
19. Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa.
Tateda K; Hirakata Y; Furuya N; Ohno A; Yamaguchi K
Antimicrob Agents Chemother; 1993 Apr; 37(4):675-80. PubMed ID: 8494362
[TBL] [Abstract][Full Text] [Related]
20. Combined action of semisynthetic penicillin and macrolide antibiotic on Pseudomonas aeruginosa in vitro and in vivo.
Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1979 Oct; 49(5):331-6. PubMed ID: 119075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
